Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.
Zafrens's investors include Liquid 2 Ventures, imec.xpand, Prime Movers Lab, Global Brain Corporation, BlueYard Capital.
Zafrens is headquartered in San Diego, United States.
Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.
Zafrens is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zafrens — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/zafrens. Accessed August 14, 2026.
VCBacked. (2025). Zafrens — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zafrens
{{cite web |title=Zafrens — Funding & Investors |url=https://www.vcbacked.co/company/zafrens |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated